Literature DB >> 3018363

Superoxide generation during cardiopulmonary bypass: is there a role for vitamin E?

N C Cavarocchi, M D England, J F O'Brien, E Solis, P Russo, H V Schaff, T A Orszulak, J R Pluth, M P Kaye.   

Abstract

The cytotoxic metabolites of oxygen [superoxide (O-2), hydrogen peroxide (H2O2), and hydroxyl (OH.)] have been demonstrated to be involved in the peroxidation of membrane lipids consequently altering membrane composition, morphology, and function. Of all the lines of defense adopted by living organisms against toxic oxygen free radicals, vitamin E is most effective in the prevention of membrane damage. Cardiopulmonary bypass (CPB) has been shown to activate complement and cause sequestration of leukocytes which can recruit, adhere, and stimulate release of cytotoxic oxygen radicals. A prospective study of 30 patients evaluated the effects of CPB with and without an exogenous free radical scavenger (Group I, N = 20, control) and (Group II, N = 10, vitamin E) on H2O2 (a marker of oxygen free radicals) malonaldehyde (a marker of lipid peroxidation), transpulmonary leukosequestration, and plasma levels of vitamins E and C. Group I showed a progressive increase in H2O2 during CPB from 65 +/- 6 to 130 +/- 11 micron/ml (P less than 0.0001); plasma vitamin E decreased from 15 +/- 3 to 6 +/- 1 mg/liter (P less than 0.0001) while vitamin C increased from 1.6 +/- .3 to 2.3 +/- .3 mg/dl (P less than 0.0001). Group II showed no significant increase in H2O2 (from 78 +/- 8 to 93 +/- 5 microns/ml) during CPB and a significant reduction in H2O2 levels compared to Group I (P less than 0.001); plasma vitamins E and C did not change significantly in Group II.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018363     DOI: 10.1016/0022-4804(86)90093-4

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

1.  Extracorporeal membrane oxygenation induced cardiac dysfunction in newborn lambs.

Authors:  Lee A Pyles; Robert A Gustafson; James Fortney; Stanley Einzig
Journal:  J Cardiovasc Transl Res       Date:  2010-09-17       Impact factor: 4.132

Review 2.  Could treatment with scavengers of oxygen free radicals minimize complications in cardiac surgery?

Authors:  J Vaage; G Valen
Journal:  Klin Wochenschr       Date:  1991-12-15

3.  Changes in plasma LDL and HDL composition in patients undergoing cardiac surgery.

Authors:  M Hacquebard; A Ducart; D Schmartz; W J Malaisse; Y A Carpentier
Journal:  Lipids       Date:  2007-10-03       Impact factor: 1.880

4.  Effect of orally administered alpha-tocopheryl acetate on human myocardial alpha-tocopherol levels.

Authors:  D A Mickle; R D Weisel; G W Burton; K U Ingold
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

5.  Prolonged granulocyte activation, as well as hypoxanthine and free radical production after open heart surgery in children.

Authors:  E J Pesonen; R Korpela; M Leijala; H Sairanen; O M Pitkänen; K O Raivio; P Venge; S Andersson
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

6.  Levels of lipid peroxidation and antioxidants in vegetarians.

Authors:  M Krajcovicová-Kudlácková; R Simoncic; K Babinská; A Béderová
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

7.  The Effect of On-Pump and Off-Pump Bypass Operations on Oxidative Damage and Antioxidant Parameters.

Authors:  Ayse Dogan; Fevzi Sarper Turker
Journal:  Oxid Med Cell Longev       Date:  2017-12-17       Impact factor: 6.543

8.  Efficacy of Allopurinol in Cardiovascular Diseases: A Systematic Review and Meta-Analysis.

Authors:  Waqas Ullah; Shristi Khanal; Rozi Khan; Bikash Basyal; Samavia Munir; Artem Minalyan; M Chadi Alraies; David L Fischman
Journal:  Cardiol Res       Date:  2020-06-03

Review 9.  Oxidative Stress after Surgery on the Immature Heart.

Authors:  Daniel Fudulu; Gianni Angelini
Journal:  Oxid Med Cell Longev       Date:  2016-03-31       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.